- Home
- FMAO vs HUMA Comparison
FMAO vs HUMA Comparison
Compare FMAO & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMAO
- HUMA
- Stock Information
- Founded
- FMAO 1897
- HUMA 2004
- Country
- FMAO United States
- HUMA United States
- Employees
- FMAO N/A
- HUMA N/A
- Industry
- FMAO Savings Institutions
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- FMAO Finance
- HUMA Health Care
- Exchange
- FMAO Nasdaq
- HUMA Nasdaq
- Market Cap
- FMAO 356.9M
- HUMA 250.2M
- IPO Year
- FMAO N/A
- HUMA N/A
- Fundamental
- Price
- FMAO $26.13
- HUMA $1.51
- Analyst Decision
- FMAO
- HUMA Strong Buy
- Analyst Count
- FMAO 0
- HUMA 8
- Target Price
- FMAO N/A
- HUMA $10.88
- AVG Volume (30 Days)
- FMAO 21.8K
- HUMA 5.9M
- Earning Date
- FMAO 10-29-2025
- HUMA 08-11-2025
- Dividend Yield
- FMAO 3.34%
- HUMA N/A
- EPS Growth
- FMAO 38.39
- HUMA N/A
- EPS
- FMAO 2.16
- HUMA N/A
- Revenue
- FMAO $108,632,000.00
- HUMA $818,000.00
- Revenue This Year
- FMAO $1.60
- HUMA N/A
- Revenue Next Year
- FMAO $13.77
- HUMA $949.92
- P/E Ratio
- FMAO $12.26
- HUMA N/A
- Revenue Growth
- FMAO 13.86
- HUMA N/A
- 52 Week Low
- FMAO $20.88
- HUMA $1.15
- 52 Week High
- FMAO $34.15
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- FMAO 58.09
- HUMA 36.87
- Support Level
- FMAO $24.60
- HUMA $1.43
- Resistance Level
- FMAO $27.01
- HUMA $1.67
- Average True Range (ATR)
- FMAO 0.81
- HUMA 0.15
- MACD
- FMAO 0.23
- HUMA -0.01
- Stochastic Oscillator
- FMAO 89.44
- HUMA 23.32
About FMAO Farmers & Merchants Bancorp Inc.
Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.